NSE · JHS
JHS Svendgaard Laboratories Limited (JHS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,237
of 5,047 stocks
▼ 81W▼ 1031M
Peak #2,891 · 02 Oct 2026
Operating in Healthcare, JHS Svendgaard Laboratories Limited has a subdued return on equity, is growing revenue at a solid clip, and has promoters holding 34%.
Market Cap
70.89 Cr
P/E Ratio
—
P/B Ratio
0.41
ROE
-1.10%
ROCE
-0.78%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 21.83 Cr | 30.38 Cr | 32.70 Cr | 23.27 Cr |
| Net Profit | 50.62 L | 1.09 Cr | -3.57 Cr | 78.89 L |
| EPS | 0.06 | 0.12 | -0.42 | 0.09 |
| Operating Profit | -7.68 L | 34.58 L | -2.76 Cr | 35.68 L |
Shareholding pattern
Promoter
33.85%
Public
66.15%
PUBLIC BREAKDOWN
FII
3.14%
Individuals
48.48%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 11 Sep 2023 | Other | Demerger |
| 06 Sep 2019 | Other | Annual General Meeting |
| 03 Sep 2018 | Other | Annual General Meeting |
| 21 Aug 2017 | Other | Annual General Meeting |
| 02 Jan 2017 | Other | Extra Ordinary General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.